Corporate VCs join Hookipa's €20m series B

Two corporate investors have joined Hookipa Biotech of Austria's €20 million ($27.5 million) series B financing. Existing investors Sofinnova Partners and Forbion Capital Partners led the financing, with three new investors, Boehringer Ingelheim Venture Fund, Takeda Ventures and BioMedPartners joining the round.